Diagnostic work-up of pleural effusions

Respiration

Volumn 75, Issue 1, 2008, Pages 4-13

  Froudarakis, Marios E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Cytology; Pleural effusion, diagnosis; Thoracoscopy

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; BROMOCRIPTINE; CARBAMAZEPINE; CYCLOPHOSPHAMIDE; DIURETIC AGENT; ERGOT DERIVATIVE; FIBRINOLYTIC AGENT; GADOLINIUM; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; NITROFURANTOIN; PENICILLAMINE; PHENYTOIN; PROCAINAMIDE; PROPYLTHIOURACIL; SULFAMIDE DERIVATIVE;

ANAMNESIS; BRONCHOSCOPY; CANCER LOCALIZATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DISEASE MARKER; ECHOGRAPHY; HEART FAILURE; HUMAN; KIDNEY FAILURE; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ASSESSMENT; PLEURA BIOPSY; PLEURA CAVITY; PLEURA EFFUSION; PLEURA FLUID; PNEUMONIA; PRIORITY JOURNAL; REVIEW; THORACOCENTESIS; THORACOSCOPY; THORAX RADIOGRAPHY;

BIOLOGICAL MARKERS; BIOPSY, NEEDLE; BRONCHOSCOPY; DIAGNOSTIC IMAGING; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PLEURAL EFFUSION; PLEURAL EFFUSION, MALIGNANT; RADIOGRAPHY, THORACIC; SENSITIVITY AND SPECIFICITY;

EID: 38049084787     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112221     Document Type: Review

References (91)

1. Miserocchi G: Physiology and pathophysiology of pleural fluid turnover. Eur Respir J 1997;10:219-225.
2. Sahn SA: Pleural diagnostic techniques. Am Rev Respir Dis 1988;138:184-234.
3. Maskell NA, Butland RJA: BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax 2003;58(suppl 2):ii8-ii17.
4. Rahman NM, Chapman SJ, Davies RJ: Pleural effusion: a structured approach to care. Br Med Bull 2004;72:31-47.
5. Antony VB, Loddenkemper R, Astoul P, Boutin C, Goldstraw P, Hott J, Rodriguez Panadero F, Sahn SA: Management of malignant pleural effusions. Eur Respir J 2001;18:402-419.
6. Estenne M, Yernault JC, DeTroyer A: Mechanism of relief of dyspnea after thoracocentesis in patients with large pleural effusions. Am J Med 1983;74:813-819.
7. Judson MA, Sahn SA: Pulmonary physiologic abnormalities caused by pleural disease. Semin Respir Crit Care Med 1995;16:346-353.
8. Froudarakis ME, Fournel P: Pleural effusion in lung carcinoma;in Bouros D (ed): Pleural Diseases. New York, Dekker, 2004, pp 439-456.
9. Light RW: Pleural effusion due to pulmonary emboli. Curr Opin Pulm Med 2001;7:198-201.
10. Becklake MR, Bagatin E, Neder JA: Asbestos-related diseases of the lungs and pleura: uses, trends and management over the last century. Int J Tuberc Lung Dis 2007;11:356-369.
11. Gallardo X, Castaner E, Mata JM: Benign pleural diseases. Eur J Radiol 2000;34:87-97.
12. Antony VB: Drug-induced pleural disease. Clin Chest Med 1998;19:331-340.
13. Light RW: The undiagnosed pleural effusion. Clin Chest Med 2006;27:309-319.
14. Sahn SA: Malignancy metastatic to the pleura. Clin Chest Med 1998;19:351-361.
15. Davidson B: Malignant effusions: from diagnosis to biology. Diagn Cytopathol 2004;31:246-254.
16. Joseph J, Sahn SA: Connective tissue diseases and the pleura. Chest 1993;104:262-270.
17. Qureshi NR, Gleeson FV: Imaging of pleural disease. Clin Chest Med 2006;27:193-213.
18. Evans AL, Gleeson FV: Radiology in pleural disease: state of the art. Respirology 2004;9:300-312.
19. Tsai TH, Yang PC: Ultrasound in the diagnosis and management of pleural disease. Curr Opin Pulm Med 2003;9:282-290.
20. McLoud TC, Flower CDR: Imaging the pleura: sonognaphy, CT, and MR imaging. AJR Am J Roentgenol 1991;156:1145-1153.
21. Light RW: Pleural Diseases, ed 4. Baltimore, Lippincott, Williams & Wilkins, 2001.
22. Martensson G, Pettersson K, Thiringer G: Differentiation between malignant and nonmalignant pleural effusion. Eur J Respir Dis 1985;67:326-334.
23. Ferrer J, Roldan J: Clinical management of the patient with pleural effusion. Eur J Radiol 2000;34:76-86.
24. Heffner JE: Discriminating between transudates and exudates. Clin Chest Med 2006;27:241-252.
25. Light RW: Useful tests on the pleural fluid in the management of patients with pleural effusions. Curr Opin Pulm Med 1999;5:245-249.
26. Light RW: Pleural effusion. N Engl J Med 2002;346:1971-1977.
27. Heffner JE: Evaluating diagnostic tests in the pleural space. Differentiating transudates from exudates as a model. Clin Chest Med 1998;19:277-293.
28. Heffner JE, Brown LK, Barbieri C, DeLeo JM: Pleural fluid chemical analysis in para - pneumonic effusions. A metaanalysis. Am J Respir Crit Care Med 1995;151:1700-1708.
29. Hamm H, Brohan U, Bohmer R, Missmahl HP: Cholesterol in pleural effusions: a diagnostic aid. Chest 1987;92:296-302.
30. Halla JT, Schronhenholer RE, Volanakis JE: Immune complexes and other laboratory features of pleural effusions. Ann Intern Med 1980;92:748-752.
31. Good JT, Khare V, Baethge B, Lang S, Wolf RE, Douglas Campbell GJ: Antinuclear antibodies in pleural fluid. Chest 1994;106:866-871.
32. Hillerdal G: Chylothorax and pseudochylothorax. Eur Respir J 1997;10:1157-1162.
33. Davies W, Kearney S, Gleeson F, Davies R: Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 2003;160:1682-1686.
34. Davies CW, Gleeson FV, Davies RJ: BTS guidelines for the management of pleural infection. Thorax 2003;58(suppl 2):ii18-ii28.
35. Bouros D, Schiza S, Tzanakis N, Drositis J, Siafakas N: Intrapleural urokinase in the treatment of complicated parapneumonic pleural effusions and empyema. Eur Respir J 1996;9:1656-1659.
36. Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N: Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999;159:37-42.
37. Davies RJ, Gleeson FV: The diagnosis and management of pleural empyema. Curr Opin Pulm Med 1998;4:185-190.
38. Chapman SJ, Davies RJ: The management of pleural space infections. Respirology 2004;9:4-11.
39. Pine JR, Hollman JL: Elevated pleural fluid pH in Proteus mirabilis empyema. Chest 1983;84:109-111.
40. Ferrer J: Pleural tuberculosis. Eur Respir J 1997;10:942-947.
41. Gopi A, Madhavan SM, Sharma SK, Sahn SA: Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007;131:880-889.
42. Chen ML, Yu WC, Lam CW, Au KM, Kong FY, Chan AY: Diagnostic value of pleural fluid adenosine deaminase activity in tuberculous pleurisy. Clin Chim Acta 2004;341:101-107.
43. Diacon AH, Van de Wal BW, Wyser C, Smedema JP, Bezuidenhout J, Bolliger CT, Walzl G: Diagnostic tools in tuberculous pleurisy: a direct comparative study. Eur Respir J 2003;22:589-591.
44. Light RW, Erozan YS, Ball WC Jr: Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973;132:854-860.
45. Light RW, Rogers JT, Cheng D, Rodriguez RM: Large pleural effusions occurring after coronary artery bypass grafting. Cardiovascular Surgery Associates, PC. Ann Intern Med 1999;130:891-896.
46. Light RW: Pleural effusions after coronary artery bypass graft surgery. Curr Opin Pulm Med 2002;8:308-311.
47. Bedrossian CW: Diagnostic problems in serous effusions. Diagn Cytopathol 1998;19:131-137.
48. Johnston WW: The malignant pleural effusion: a review of cytopathologic diagnosis of 584 specimens from 472 consecutive patients. Cancer 1985;56:905-909.
49. Alatas F, Alatas O, Metintas M, Colak O, Harmanci E, Demir S: Diagnostic value of CEA, CA 15-3, CA 19-9, CYFRA 21-1, NSE and TSA assay in pleural effusions. Lung Cancer 2001;31:9-16.
50. Cascinu S, Del Ferro E, Barbanti I, Ligi M, Fedeli A, Catalano G: Tumor markers in the diagnosis of malignant serous effusions. Am J Clin Oncol 1997;20:247-250.
51. Miedouge M, Rouzaud P, Salama G, Pujazon MC, Vincent C, Mauduyt MA, Reyre J, Carles P, Serre G: Evaluation of seven tumour markers in pleural fluid for the diagnosis of malignant effusions. Br J Cancer 1999;81:1059-1065.
52. Menard O, Dousset B, Jacob C, Martinet Y: Improvement of the diagnosis of the cause of pleural effusion in patients with lung cancer by simultaneous quantification of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) pleural levels. Eur J Cancer 1993;13:1806-1809.
53. Toumbis M, Rasidakis A, Passalidou E, Kalomenidis J, Alchanatis M, Orphanidou D, Jordanoglou J: Evaluation of CYFRA 21-1 in malignant and benign pleural effusions. Anticancer Res 1996;16:2101-2104.
54. Falcone F, Marinelli M, Minguzzi L, Paganelli GM, Turba E, Cavalli A, Rapellino M: Tumor markers and lung cancer: guidelines in a cost-limited medical organization. Int J Biol Markers 1996;11:61-66.
55. Alexandrakis MG, Coulocheri SA, Bouros D, Vlachonikolis IG, Eliopoulos GD: Significance of alpha-2-macroglobulin, alpha-1-acid glycoprotein, and C-reactive protein in pleural effusion differentiation. Respiration 2000;67:30-35.
56. Stoetzer OJ, Munker R, Darsow M, Wilmanns W: P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining. Oncol Rep 1999;6:455-458.
57. Alexandrakis MG, Coulocheri SA, Bouros D, Mandalaki K, Karkavitsas N, Eliopoulos GD: Evaluation of inflammatory cytokines in malignant and benign pleural effusions. Oncol Rep 2000;7:1327-1332.
58. Alexandrakis MG, Kyriakou D, Alexandraki R, Pappa KA, Antonakis N, Bouros D: Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters. Respiration 2002;69:201-206.
59. Hurewitz AN, Zucker S, Mancuso P, Wu CL, Dimassimo B, Lysik RM, Moutsiakis D: Human pleural effusions are rich in matrix metalloproteinases. Chest 1992;102:1808-1814.
60. Antony VB: Drawing the line: differentiating transudates from exudates. Respiration 2002;69:198.
61. Marel M, Stastny B, Melinova L, Svandova E, Light RW: Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990. Chest 1995;107:1598-1603.
62. Edmondstone WM: Investigation of pleural effusion: comparison between fibreoptic thoracoscopy, needle biopsy and cytology. Respir Med 1990;84:23-26.
63. Canto A, Rivas J, Saumench J, Morera R, Moya J: Points to consider when choosing a biopsy method in cases of pleurisy of unknown origin. Chest 1983;84:176-179.
64. Walshe AD, Douglas JG, Kerr KM, McKean ME, Godden DJ: An audit of the clinical investigation of pleural effusion. Thorax 1992;47:734-737.
65. Jimenez D, Perez-Rodriguez E, Diaz G, Fogue L, Light RW: Determining the optimal number of specimens to obtain with needle biopsy of the pleura. Respir Med 2002;96:14-17.
66. Rodriguez-Panadero F, Borderas Naranjo F, Lopez Mejias J: Pleural metastatic tumours and effusions. Frequency and pathogenic mechanisms in a post-mortem series. Eur Respir J 1989;2:366-369.
67. Vassilakis DA, Wells AU, Bouros D: Immunological diseases of the pleura;in Bouros D (ed): Pleural Diseases. New York, Dekker, 2004, pp 595-620.
68. Colt HG: Thoracoscopy: window to the pleural space. Chest 1999;116:1409-1415.
69. Mathur PN, Astoul P, Boutin C: Medical thoracoscopy: technical details. Clin Chest Med 1995;16:479-486.
70. Boutin C, Astoul P: Diagnostic thoracoscopy. Clin Chest Med 1998;19:295-309.
71. Boutin C, Viallat JR, Cargnino P, Farisse P: Thoracoscopy in malignant pleural effusions. Am Rev Respir Dis 1981;124:588-592.
72. Boutin C, Viallat JR, Cargnino P, Farisse P: Indications actuelles de la thoracoscopie. Compte rendu du Symposium de Marseille. Rev Fr Mal Respir 1981;9:309-318.
73. Boutin C, Loddenkemper R, Astoul P: Diagnostic and therapeutic thoracoscopy: techniques and indications in pulmonary medicine. Tuber Lung Dis 1993;74:225-239.
74. Roeslin N, Kessler R: Quelle est la place de la thoracoscopie dans le bilan d'extension préopératoire du cancer bronchique non àpetites cellules? Rev Mal Respir 1992;9:R247-R251.
75. Loddenkemper R: Thoracoscopy - state of the art. Eur Respir J 1998;11:213-221.
76. Rodriguez-Panadero F, Janssen JP, Astoul P: Thoracoscopy: general overview and place in the diagnosis and management of pleural effusion. Eur Respir J 2006;28:409-422.
77. Harris RJ, Kavuru MS, Mehta AC, Medendorp SV, Wiedemann HP, Kirby TJ, Rice TW: The impact of thoracoscopy on the management of pleural disease. Chest 1995;107:845-852.
78. Kendall SW, Bryan AJ, Large SR, Wells FC: Pleural effusions: is thoracoscopy a reliable investigation? A retrospective review. Respir Med 1992;86:437-440.
79. Venekamp LN, Velkeniers B, Noppen M: Does 'idiopathic pleuritis' exist? Natural history of non-specific pleuritis diagnosed after thoracoscopy. Respiration 2005;72:74-78.
80. Janssen JP, Ramlal S, Mravunac M: The long term follow-up of exudative pleural effusion after non-diagnostic thoracoscopy. J Bronchol 2004;11:169-174.
81. Canto A, Ferrer G, Romagosa V, Moya J, Bernat R: Lung cancer and pleural effusion. Clinical significance and study of pleural metastatic locations. Chest 1985;87:649-652.
82. Scherpereel A; French Speaking Society for Chest Medicine (SPLF) Experts Group: Guidelines of the French Speaking Society for Chest Medicine for management of malignant pleural mesothelioma. Respir Med 2007;101:1265-1276.
83. Astoul P: Diagnostique clinique et endoscopique du mésothé liome pleural; in Astoul P (ed): Mésothéliome pleural. Paris, Elsevier, 2005, pp 77-88.
84. Colt HG: Thoracoscopic management of malignant pleural effusions. Clin Chest Med 1995;16:505-518.
85. Bouros D, Froudarakis M, Siafakas NM: Pleurodesis: everything flows. Chest 2000;118:577-579.
86. Rodriguez-Panadero F, Antony VB: Pleurodesis: state of the art. Eur Respir J 1997;10:1648-1654.
87. Janssen JP, Collier G, Astoul P, Tassi GF, Noppen M, Rodriguez-Panadero F, Loddenkemper R, Herth FJ, Gasparini S, Marquette CH, Becke B, Froudarakis ME, Driesen P, Bolliger CT, Tschopp JM: Safety of pleurodesis with talc poudrage in malignant pleural effusion: a prospective cohort study. Lancet 2007;369:1535-1539.
88. Froudarakis ME, Klimathianaki M, Pougounias M: Systemic inflammatory reaction after thoracoscopic talc poudrage. Chest 2006;129:356-361.
89. Vergnon JM, Froudarakis M: Bronchoscopy; in Grassi C (ed): Pulmonary Diseases. London, McGraw-Hill International, 1999, pp 39-43.
90. Poe RH, Levy PC, Israel RH, Ortiz CR, Kalley MC: Use of fiberoptic bronchoscopy in the diagnosis of bronchogenic carcinoma. A study in patients with idiopathic pleural effusions. Chest 1994;105:1663-1667.
91. Antunes G, Neville E, Duffy J, Ali N: BTS guidelines for the management of malignant pleural effusions. Thorax 2003;58(suppl 2):ii29-ii38.